AEON Biopharma
Unlocking the promise of therapeutic neurotoxins
United States · Founded 2012
- Employees
- 1–10
- Founded
- 2012
- Business Model
- B2B
- Website
- aeonbiopharma.com
About
At AEON Biopharma, we focus exclusively on expanding the therapeutic use of botulinum toxins in patients with debilitating neuromuscular disorders. Our lead product, ABP-450, is being developed as a branded biosimilar to BOTOX, designed to expand access to high-quality therapeutic neurotoxin treatments and deliver meaningful value across the healthcare system. The team's expertise in developing and commercializing neurotoxins guides biosimilarity science intended to improve access for patients living with painful and often intractable conditions.
Summary
AEON Biopharma is a Biotech company based in United States, founded in 2012.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/aeon-biopharma"><img src="https://indexed.vc/api/badge/company/aeon-biopharma" alt="AEON Biopharma on Indexed.vc" width="260" height="76" /></a>